Medical Lasers

Korean Society for Laser Medicine and Surgery (대한의학레이저학회)
권호 표지
DOI QR코드

DOI QR Code

Low-level Laser Therapy with Novel Array of Light Source and Individualized Program for Treatment of Androgenetic Alopecia: A 16-week, Randomized, Double-blind, Sham Device-controlled Study

  • Kim, Jee-Woo (Department of Dermatology, Seoul National University Bundang Hospital) ;
  • Kwon, Yeo-Seon (Home Entertainment Company, LG Electronics) ;
  • Chang, Yoon-Young (Beauty/Medical Task, E&M center, CTO, LG Electronics) ;
  • Hong, Sung-Ho (Beauty/Medical Task, E&M center, CTO, LG Electronics) ;
  • Shin, Jung-Won (Department of Dermatology, Seoul National University Bundang Hospital) ;
  • Na, Jung-Im (Department of Dermatology, Seoul National University Bundang Hospital) ;
  • Huh, Chang-Hun (Department of Dermatology, Seoul National University Bundang Hospital)
  • Received : 2020.09.29
  • Accepted : 2020.10.08
  • Published : 2020.12.31
⟨ Previous Next ⟩

Abstract

Background and Objectives Low-level laser therapy (LLLT) is used widely to promote hair growth in androgenetic alopecia (AGA). This study examined the clinical efficacy and safety of a home-use LLLT device with a newly designed array of light sources and software optimized for individual types of AGA. Materials and Methods The study was a randomized, double-blind, sham device-controlled trial. Forty-eight subjects (39 men and nine women) were assigned randomly in a 2:1 ratio to use either the test device (LG Pra'L HGN1, LG electronics, Korea) or sham device. The subjects used the LLLT device three times a week for 16 weeks. Phototrichogram was used to measure the hair density and hair thickness at 0, 8, and 16-weeks. Adverse events were closely monitored. Results After 16 weeks of using the device, the test group showed a significant increase in hair density and hair thickness compared to the control. In the test group, the hair density increased 6.96 counts/cm2 at eight weeks and 13.67 counts/cm2 at 16 weeks from the baseline. The hair thickness increased 7.21 ㎛ at eight weeks and 11.80 ㎛ at 16 weeks compared to the baseline. Conclusion The home-use LLLT device with a novel array of light sources and an individualized program according to the types of hair loss appears to be an effective and safe treatment modality for both male and female AGA patients.

Keywords

Acknowledgement

LG Electronics.

References

  1. Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol 1993;29:568-75. https://doi.org/10.1016/0190-9622(93)70223-G
  2. Han SH, Byun JW, Lee WS, Kang H, Kye YC, Kim KH, et al. Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study. Ann Dermatol 2012;24:311-8. https://doi.org/10.5021/ad.2012.24.3.311
  3. Jang WS, Son IP, Yeo IK, Park KY, Li K, Kim BJ, et al. The annual changes of clinical manifestation of androgenetic alopecia clinic in Korean males and females: a outpatient-based study. Ann Dermatol 2013;25:181-8. https://doi.org/10.5021/ad.2013.25.2.181
  4. Tosti A, Iorizzo M, Piraccini BM. Androgenetic alopecia in children: report of 20 cases. Br J Dermatol 2005;152:556-9. https://doi.org/10.1111/j.1365-2133.2004.06279.x
  5. Rebora A. Pathogenesis of androgenetic alopecia. J Am Acad Dermatol 2004;50:777-9. https://doi.org/10.1016/j.jaad.2003.11.073
  6. Avci P, Gupta GK, Clark J, Wikonkal N, Hamblin MR. Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med 2014;46:144-51. https://doi.org/10.1002/lsm.22170
  7. Afifi L, Maranda EL, Zarei M, Delcanto GM, Falto-Aizpurua L, Kluijfhout WP, et al. Low-level laser therapy as a treatment for androgenetic alopecia. Lasers Surg Med 2017;49:27-39. https://doi.org/10.1002/lsm.22512
  8. Kim H, Choi JW, Kim JY, Shin JW, Lee SJ, Huh CH. Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial. Dermatol Surg 2013;39:1177-83. https://doi.org/10.1111/dsu.12200
  9. Gupta AK, Foley KA. A critical assessment of the evidence for low-level laser therapy in the treatment of hair loss. Dermatol Surg 2017;43:188-97. https://doi.org/10.1097/DSS.0000000000000904
  10. Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges 2011;9:S1-57.
  11. Avram MR, Leonard RT Jr, Epstein ES, Williams JL, Bauman AJ. The current role of laser/light sources in the treatment of male and female pattern hair loss. J Cosmet Laser Ther 2007;9:27-8. https://doi.org/10.1080/14764170601134479
  12. Ghanaat M. Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism. South Med J 2010;103:917-21. https://doi.org/10.1097/smj.0b013e3181ebcf71
  13. Suchonwanit P, Chalermroj N, Khunkhet S. Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial. Lasers Med Sci 2019;34:1107-14. https://doi.org/10.1007/s10103-018-02699-9
  14. Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review. J Clin Aesthet Dermatol 2016;9:56-62.